
Vinay Singh
About Vinay Singh
Data last updated:
Vinay Singh is a Director at V&P Sattava Private Limited (since 2018) and Designated Partner at Raxom Pharmaceuticals Llp (since 2025). The companies operate in Food and Beverages and Pharma. The largest current company by reported revenue is V&P Sattava Private Limited at ₹9.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Nov 2018 | 2018 | ₹9.61 Cr (FY 2024) | Active | |
| Designated Partner | 27 Oct 2025 | 2025 | Active |
Board colleagues of Vinay Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pankaj Kumar Pandey | 09684617 | V&P Sattava Private Limited | Additional Director |
| Sudipa Das | 11356327 | Raxom Pharmaceuticals Llp | Designated Partner |
| Vishal Balkrishna Dalbhanjan | 11356328 | Raxom Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vinay Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vinay Singh
Vinay Singh currently holds 2 directorships: V&P Sattava Private Limited (Director, since 28 Nov 2018, revenue ₹9.61 Cr (FY 2024)); Raxom Pharmaceuticals Llp (Designated Partner, since 27 Oct 2025).
Vinay Singh was first appointed on 28 Nov 2018 as Director at V&P Sattava Private Limited. The most recent appointment on record is 27 Oct 2025 at Raxom Pharmaceuticals Llp.
The current boards of Vinay Singh's companies include Pankaj Kumar Pandey (V&P Sattava Private Limited), Sudipa Das (Raxom Pharmaceuticals Llp), Vishal Balkrishna Dalbhanjan (Raxom Pharmaceuticals Llp).